Clinical Trial Update: Retina is a Marker for Cerebrovascular Heath [Phase 1, Phase 2]

View source ↗

Summary

A Mayo Clinic–led trial is evaluating whether the retina can serve as a biomarker for cerebrovascular health, with Phase 1 and Phase 2 currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cadasil
• Cerebral Microbleeds
• Cerebral Small Vessel Disease
• White Matter Disease

Snippet

Sponsor: Mayo Clinic | Conditions: Cerebral Small Vessel Diseases, Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy | Phase 1, Phase 2 | Status: RECRUITING